Olive Leaf Extract in Handball Players
Effects of Short-Term Olive Leaf Extract Supplementation in Elite Male Handball Players
1 other identifier
interventional
18
1 country
1
Brief Summary
Olive leaf extract (OLE) is a natural supplement rich in phenolic compounds, especially oleuropein, which has antioxidant properties that may support recovery after physical exercise. While OLE has been studied for various health-related effects, its potential impact on exercise recovery and performance in elite athletes remains unclear. This randomized, double-blind, placebo-controlled study was designed to evaluate the effects of four weeks of OLE supplementation on physical performance, sleep quality, and post-exercise muscle soreness in elite male handball players aged 18 to 25 years. Participants were randomly assigned to receive either a daily OLE supplement (500 mg, standardized to 25% oleuropein) or a placebo for four weeks. Physical performance, sleep quality, and muscle soreness were assessed at baseline, during the intervention, and at the end of the study period. Muscle soreness was additionally evaluated at 12 and 24 hours following exercise sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedJanuary 27, 2026
January 1, 2026
14 days
January 15, 2026
January 22, 2026
Conditions
Outcome Measures
Primary Outcomes (6)
Muscle Soreness
The severity of muscle soreness will be assessed using the Visual Analog Scale (VAS). Patients choose the appropriate score between 0 and 10. Higher scores indicate higher muscle soreness levels.
Baseline, After intervention (two week later), After intervention (fourt week later)
Squat jump height
Lower-body explosive performance was assessed using the squat jump test. Jump height was measured in centimeters (cm) with higher values indicating better explosive performance.
Performance outcomes were assessed at baseline, week 2, and week 4 of the intervention period.
Peak anaerobic power
Peak anaerobic power was assessed using the Wingate anaerobic test. Peak power output was recorded in watts (W) during the 30-second maximal cycling test. Higher values indicate greater anaerobic power.
baseline, week 2, and week 4.
Countermovement jump height
Lower-body explosive performance was assessed using the countermovement jump test. Jump height was measured in centimeters (cm) with higher values indicating better explosive performance.
Assessments were conducted at baseline, week 2, and week 4. Higher values indicate better explosive performance.
Mean anaerobic power
Mean anaerobic power was assessed using the Wingate anaerobic test. Mean power output was calculated as the average power produced over the 30-second test and recorded in watts (W). Higher values indicate better anaerobic capacity.
Baseline, week 2, and week 4
Fatigue index
Fatigue index was assessed using the Wingate anaerobic test and calculated as the percentage decline in power output from peak to minimum power during the 30-second test. Higher values indicate greater fatigue.
Baseline, week 2, and week 4
Secondary Outcomes (1)
Sleep quality
Total PSQI scores were recorded at baseline, week 2, and week 4 to evaluate changes in perceived sleep quality during the supplementation period.
Study Arms (2)
Study group
EXPERIMENTALolive leaf extract supplemented
Control group
PLACEBO COMPARATORplacebo capsule supplemented
Interventions
OLE supplement (500 mg, standardized to 25% oleuropein)
Eligibility Criteria
You may qualify if:
- Male elite handball players aged 18 years or older
- Free from any diagnosed chronic disease, as determined by medical history
- Not following a calorie-restricted diet within the previous six months
- No use of nutritional supplements within the previous six months
You may not qualify if:
- Age under 18 years
- Smoking or alcohol consumption
- Presence of any diagnosed chronic disease
- Adherence to a regular calorie-restricted diet within the previous six months
- Use of nutritional supplements during the previous six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karabuk University
Karabük, Central, 78050, Turkey (Türkiye)
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- double blind (participant investigator)
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Research Assistant, Nutritients
Study Record Dates
First Submitted
January 15, 2026
First Posted
January 27, 2026
Study Start
January 1, 2025
Primary Completion
January 15, 2025
Study Completion
February 1, 2025
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share